• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pressure Biosciences Inc (OP:PBIO)

0.0007 UNCHANGED
Last Price Updated: 9:58 AM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pressure Biosciences Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Pressure BioSciences to Participate in FORCE Family Office's January 20th Webinar: Innovations and Advancements in the $4.6 Billion CBD Market
January 19, 2022
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Fireside Chat SOUTH EASTON, MA / ACCESSWIRE / January 19, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI"... 
From Pressure BioSciences Inc.
Via AccessWire
News headline image
This Company Believes Physics, Not Chemistry, Is the Best Way To Develop Successful Protein Therapeutics ↗
January 13, 2022
Picture credit: Michael Longmire on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing... 
Via Benzinga
News headline image
Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability ↗
December 22, 2021
UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets South Easton, MA, December 22, 2021 – Pressure BioSciences, Inc. (... 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Scalable UST(TM) Process Shown to Create Rock-Solid 18-Month Stability
December 22, 2021
Via Investor Brand Network
News headline image
Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability
December 22, 2021
UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets SOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO)... 
From Pressure BioSciences Inc.
Via AccessWire
News headline image
The Use of High Pressure is Transforming the Nutraceuticals (CBD), Food & Beverage, Healthcare, and other Billion-Dollar Markets ↗
December 14, 2021
Image Provided By Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
News headline image
Is High Pressure Good for Drug Development? ↗
December 02, 2021
Picture credit: National Cancer Institute The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
News headline image
Oil and Water Don't Mix, But This Company - Armed with Newly Awarded Patents and Proprietary Knowhow - Wants to Change That ↗
November 18, 2021
Photo by Sharon Pittaway on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Topics Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2021 Financial Report
November 17, 2021
Via Investor Brand Network
News headline image
Pressure BioSciences, Inc. Q3 Financial Results Maintain Solid 2021 YTD Growth
November 17, 2021
Operational and Technical Achievements Set Stage for Expected Major Growth and Profitability in 2022 Investor Call Scheduled for Wednesday, November 17, 2021 at 4:30 p.m. ET SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Regulatory Compliance
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve
November 11, 2021
Via Investor Brand Network
Topics Intellectual Property
News headline image
Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve
November 11, 2021
Dynamically-Adaptive Compact Valve is Key Component in the Company's Highly Anticipated and Proprietary UST Platform; UST Expected to Help Deliver Strong Sales Growth and Profitability in 2022 SOUTH... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
Pressure BioSciences' BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI's Protein Refolding Technology ↗
November 05, 2021
South Easton, MA, November 4, 2021 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale... 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics
November 04, 2021
Via Investor Brand Network
Topics Intellectual Property
News headline image
Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology
November 04, 2021
Titans and Emerging Leaders of Biopharma Struggling with Protein Misfolding and Aggregation Issues that Threaten Enormous Revenue Potentials Are Turning to PBI's Uniquely Enabling BaroFold Solution... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at First-of-Its-Kind Benzinga ALL ACCESS Investor Event
November 02, 2021
Via Investor Brand Network
News headline image
Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event
November 02, 2021
Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021 SOUTH EASTON, MA / ACCESSWIRE /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance Supply Chain
News headline image
Boston Named World's Top Biotech Hub as the City's Leading Biotech Companies Continue to Make Major Breakthroughs ↗
October 27, 2021
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
News headline image
Top Astaxanthin Producers Turning to Pressure BioSciences to Increase Quality and Scale Production of World's Most Potent Antioxidant ↗
October 21, 2021
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Changes Neem Oil into Novel Nanoemulsion through Patented UST Platform
October 01, 2021
Via Investor Brand Network
News headline image
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts ↗
October 01, 2021
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications... 
Via Benzinga
News headline image
Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications
September 30, 2021
Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Small Cap Conferences
September 29, 2021
Via Investor Brand Network
News headline image
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts
September 29, 2021
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA /... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022
September 28, 2021
Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
Pressure BioSciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces ↗
September 13, 2021
Image Provided By Pixabay Pressure BioSciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technologies, has been aggressively pursuing... 
Via Benzinga
News headline image
Pressure BioSciences, Inc. Reports Escalating Quarterly Revenue, Major Progress in Key Platform Technologies, and Formation of Eco-Friendly Agrochem Subsidiary that Already Posted Over $1 Million in Orders ↗
September 09, 2021
Image Provided By Pexels... 
Via Benzinga
News headline image
Pressure Biosciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces ↗
August 27, 2021
Image Provided By Pixabay Pressure Biosciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technology, has been aggressively pursuing... 
Via Benzinga
News headline image
Pressure BioSciences Reports Strong 2nd Quarter Financial and Business Results; Looks Forward to an Even Stronger 2nd Half of 2021 ↗
August 26, 2021
Image Provided By Pixabay Pressure BioSciences, ... 
Via Benzinga
News headline image
Pressure BioSciences, Inc. Reports Strong Second Quarter 2021 Financial Results
August 19, 2021
Significant Growth Reported in Total Revenue (127%), Instrument Sales (178%), and BaroFold/UST Services (298%); Significant Decrease in Operating Loss (51%) Achieved Investor Call Scheduled for... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Intellectual Property Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap